Recent studies show that antimalarial drugs chloroquine and hydroxychloroquine did not prevent patients from being infected with the coronavirus. Officials also claim the benefits did not outweigh the risks of taking the treatment.
The anti-malaria drug promoted by United States President Donald Trump failed to prevent people from contracting the COVID-19 disease. Scientists from the University of Minnesota and Canada conducted a study involving 821 people who had been exposed to the virus.
